JP2022534433A5 - - Google Patents
Info
- Publication number
- JP2022534433A5 JP2022534433A5 JP2021570997A JP2021570997A JP2022534433A5 JP 2022534433 A5 JP2022534433 A5 JP 2022534433A5 JP 2021570997 A JP2021570997 A JP 2021570997A JP 2021570997 A JP2021570997 A JP 2021570997A JP 2022534433 A5 JP2022534433 A5 JP 2022534433A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- gal9
- immune cells
- activated immune
- control agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025107319A JP2025146842A (ja) | 2019-05-31 | 2025-06-25 | 抗gal9免疫阻害性結合分子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962855590P | 2019-05-31 | 2019-05-31 | |
| US62/855,590 | 2019-05-31 | ||
| US201962900105P | 2019-09-13 | 2019-09-13 | |
| US62/900,105 | 2019-09-13 | ||
| PCT/AU2020/050546 WO2020237320A1 (en) | 2019-05-31 | 2020-05-29 | Anti-gal9 immune-inhibiting binding molecules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025107319A Division JP2025146842A (ja) | 2019-05-31 | 2025-06-25 | 抗gal9免疫阻害性結合分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022534433A JP2022534433A (ja) | 2022-07-29 |
| JP2022534433A5 true JP2022534433A5 (cg-RX-API-DMAC7.html) | 2023-06-07 |
| JP7797203B2 JP7797203B2 (ja) | 2026-01-13 |
Family
ID=73552467
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570997A Active JP7797203B2 (ja) | 2019-05-31 | 2020-05-29 | 抗gal9免疫阻害性結合分子 |
| JP2025107319A Withdrawn JP2025146842A (ja) | 2019-05-31 | 2025-06-25 | 抗gal9免疫阻害性結合分子 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025107319A Withdrawn JP2025146842A (ja) | 2019-05-31 | 2025-06-25 | 抗gal9免疫阻害性結合分子 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20220227873A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3976102A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7797203B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220030934A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2020285369A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3141640A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL288561A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202113132YA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020237320A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202113222PA (en) * | 2019-05-31 | 2021-12-30 | Council Queensland Inst Medical Res | Activating anti-gal9 binding molecules |
| TW202400639A (zh) * | 2022-05-13 | 2024-01-01 | 美商艾克塞里克斯公司 | 5t4結合劑及其用途 |
| CN117624360A (zh) * | 2022-08-26 | 2024-03-01 | 南京融捷康生物科技有限公司 | 一种抗trem2的单域抗体及其用途 |
| KR20250159082A (ko) * | 2023-01-27 | 2025-11-07 | 엑셀리시스, 인코포레이티드 | Nkg2a 결합제 및 이의 용도 |
| WO2025129132A1 (en) * | 2023-12-14 | 2025-06-19 | Invenra Inc. | Multispecific binding agents that target ctla4 and/or cd25 and uses thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010084999A1 (en) * | 2009-01-26 | 2010-07-29 | Protegene, Inc. | Immunosuppressive agents and prophylactic and therapeutic agents for autoimmune diseases |
| CA2954678A1 (en) * | 2014-07-14 | 2016-01-21 | The Council Of The Queensland Institute Of Medical Research | Galectin immunotherapy |
-
2020
- 2020-05-29 KR KR1020217040007A patent/KR20220030934A/ko active Pending
- 2020-05-29 WO PCT/AU2020/050546 patent/WO2020237320A1/en not_active Ceased
- 2020-05-29 EP EP20813440.3A patent/EP3976102A4/en active Pending
- 2020-05-29 CA CA3141640A patent/CA3141640A1/en active Pending
- 2020-05-29 US US17/614,460 patent/US20220227873A1/en active Pending
- 2020-05-29 AU AU2020285369A patent/AU2020285369A1/en active Pending
- 2020-05-29 SG SG11202113132YA patent/SG11202113132YA/en unknown
- 2020-05-29 JP JP2021570997A patent/JP7797203B2/ja active Active
-
2021
- 2021-11-30 IL IL288561A patent/IL288561A/en unknown
-
2025
- 2025-06-25 JP JP2025107319A patent/JP2025146842A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220135676A1 (en) | Multispecific antigen binding proteins | |
| CA3211163A1 (en) | Trispecific antibody targeting bcma, gprc5d, and cd3 | |
| JP2022514693A5 (cg-RX-API-DMAC7.html) | ||
| CN110536903A (zh) | 抗ox40抗体及其用途 | |
| JP2019201643A5 (cg-RX-API-DMAC7.html) | ||
| WO2015197582A1 (en) | Monomeric multispecific antigen binding proteins | |
| WO2018108106A1 (zh) | 抗cd19的人源化抗体以及靶向cd19的免疫效应细胞 | |
| US20230114801A1 (en) | MINIATURE GUIDANCE AND NAVIGATION CONTROL (miniGNC) ANTIBODY-LIKE PROTEINS AND METHODS OF MAKING AND USING THEREOF | |
| RU2018135247A (ru) | БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА К CD25 И Fc ГАММА-РЕЦЕПТОРУ ДЛЯ ЭЛИМИНАЦИИ ОПУХОЛЕСПЕЦИФИЧЕСКИХ КЛЕТОК | |
| JP2018510636A5 (cg-RX-API-DMAC7.html) | ||
| JP2021524478A5 (cg-RX-API-DMAC7.html) | ||
| JP2018501297A (ja) | Cd3/cd38 t細胞再標的化ヘテロ二量体免疫グロブリン及びその製造方法 | |
| RU2018126297A (ru) | Антитела, нацеленные на cd32b, и способы их применения | |
| WO2009140348A4 (en) | Anti-il-6/il-6r antibodies and methods of use thereof | |
| RU2012122203A (ru) | Композиции и способы для лечения восполительных нарушений | |
| JP2012501670A5 (cg-RX-API-DMAC7.html) | ||
| GB2578037A (en) | Therapeutic anti-CD40 ligand antibodies | |
| JP2013509158A5 (cg-RX-API-DMAC7.html) | ||
| JP2020518248A5 (cg-RX-API-DMAC7.html) | ||
| EP3713959A1 (en) | Multispecific antigen binding proteins | |
| JP2021520201A5 (cg-RX-API-DMAC7.html) | ||
| WO2023060277A1 (en) | Composition of multispecific antibodies targeting cdh17-expressing tumors and method of making and using thereof | |
| JP2026048732A5 (cg-RX-API-DMAC7.html) | ||
| CN111886023A (zh) | 针对tim-3的抗体及其用途 | |
| CN108276492A (zh) | 抗pd-l1单克隆抗体及其应用 |